ALS Ltd. (AU:ALQ)
ASX:ALQ
Top Page
ALS
(Sydney:ALQ)
Select Model
Select Model
Rating:66Neutral
Price Target:
AU$24.50
â–²(16.95% Upside)
Action:ReiteratedDate:10/02/25
ALS's strong financial performance is the most significant factor, supported by robust revenue growth and profitability. Technical analysis indicates a bullish trend, though caution is advised due to overbought signals. The valuation suggests the stock may be overvalued, which slightly offsets the positive financial and technical outlook.
Positive Factors
Sustained revenue growth
ALS’s double-digit revenue growth (18.18% reported) indicates durable expansion of testing volumes and client demand across end markets. Sustained top-line growth supports capacity utilization, long-term contract wins and reinvestment in labs and services, strengthening recurring revenue over months.
Negative Factors
Exposure to commodity and project cycle volatility
A meaningful portion of ALS’s revenue comes from minerals and project-driven testing, which is sensitive to commodity exploration and production cycles. This structural exposure can cause sizable swings in sample volumes, utilization and revenue visibility, pressuring cash flow and planning during downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained revenue growth
ALS’s double-digit revenue growth (18.18% reported) indicates durable expansion of testing volumes and client demand across end markets. Sustained top-line growth supports capacity utilization, long-term contract wins and reinvestment in labs and services, strengthening recurring revenue over months.
Read all positive factors
ALS (ALQ) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$10.63B
Dividend Yield1.75%
Average Volume (3M)1.43M
Price to Earnings (P/E)17.5
Beta (1Y)1.24
Revenue Growth18.18%
EPS Growth4272.22%
CountryAU
Employees19,565
SectorIndustrials
Sector Strength72
IndustryConsulting Services
Share Statistics
EPS (TTM)0.35
Shares Outstanding507,542,540
10 Day Avg. Volume1,514,219
30 Day Avg. Volume1,429,263
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)5.83
Price to Sales (P/S)2.49
P/FCF Ratio30.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$25.57Price Target Upside22.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)0.91
Revenue Forecast (FY)AU$3.71B
ALS Business Overview & Revenue Model
Company Description
ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, North Africa, and the Americas. The company operates through three segments: Life...
How the Company Makes Money
ALS primarily makes money by charging fees for testing and analytical services delivered through its laboratories and on-site/field operations. Key revenue streams typically include: (1) Commodities/minerals services—sample preparation, geochemica...
ALS Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
70
Positive
Cash Flow
75
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.19B | 3.00B | 2.46B | 2.28B | 1.95B | 1.76B |
| Gross Profit | 810.60M | 2.69B | 2.19B | 828.60M | 693.90M | 561.70M |
| EBITDA | 678.20M | 675.00M | 641.40M | 591.30M | 439.10M | 415.40M |
| Net Income | 271.10M | 256.20M | 12.90M | 291.20M | 190.50M | 169.60M |
Balance Sheet | ||||||
| Total Assets | 4.11B | 4.06B | 3.70B | 3.33B | 2.84B | 2.48B |
| Cash, Cash Equivalents and Short-Term Investments | 211.20M | 268.00M | 299.90M | 179.60M | 122.80M | 168.60M |
| Total Debt | 1.76B | 2.09B | 1.87B | 1.45B | 1.24B | 967.70M |
| Total Liabilities | 2.43B | 2.77B | 2.50B | 1.95B | 1.71B | 1.40B |
| Stockholders Equity | 1.68B | 1.28B | 1.18B | 1.37B | 1.12B | 1.07B |
Cash Flow | ||||||
| Free Cash Flow | 194.00M | 244.60M | 198.40M | 293.80M | 167.90M | 184.70M |
| Operating Cash Flow | 441.80M | 409.60M | 350.10M | 439.90M | 286.80M | 265.80M |
| Investing Cash Flow | -253.50M | -327.70M | -226.80M | -267.00M | -405.90M | -120.50M |
| Financing Cash Flow | -251.40M | -120.00M | -3.10M | -121.20M | 77.40M | -379.90M |
ALS Technical Analysis
Neutral
20.95
Price Trends
23.14
Negative
22.61
Negative
20.84
Positive
Market Momentum
-0.79
Negative
44.15
Neutral
77.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ALQ, the sentiment is Neutral. The current price of 20.95 is below the 20-day moving average (MA) of 21.17, below the 50-day MA of 23.14, and above the 200-day MA of 20.84, indicating a neutral trend. The MACD of -0.79 indicates Negative momentum. The RSI at 44.15 is Neutral, neither overbought nor oversold. The STOCH value of 77.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:ALQ.
ALS Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | AU$10.63B | 17.54 | 18.38% | 1.75% | 18.18% | 4272.22% | |
66 Neutral | AU$1.45B | 12.97 | 9.26% | 1.30% | 15.14% | -7.23% | |
65 Neutral | AU$2.81B | 10.17 | 20.27% | 2.65% | 7.20% | 32.60% | |
64 Neutral | AU$5.13B | 14.22 | 7.97% | 3.11% | -4.53% | 97.67% | |
64 Neutral | AU$4.30B | 18.35 | 47.41% | 3.56% | 1.48% | 25.46% | |
64 Neutral | AU$2.47B | 8.10 | 7.79% | 3.20% | 12.18% | -73.81% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
* Industrials Sector Average
AU:ALQ
ALS
20.95
6.86
48.70%
AU:DOW
Downer EDI Limited
7.77
2.79
55.99%
AU:MND
Monadelphous Group Limited
28.05
14.43
105.87%
AU:NWH
NRW Holdings Limited
5.37
3.01
127.45%
AU:VNT
Ventia Services Group Limited
5.22
1.38
36.04%
AU:MGH
MAAS Group Holdings Ltd.
4.02
0.57
16.39%
ALS Corporate Events
ALS Issues New Unquoted Performance Rights Under Employee Incentive Scheme
Jan 11, 2026
ALS Limited has notified the market of the issue of 6,068 unquoted performance rights under its employee incentive scheme, which are not intended to be quoted on the ASX. The new securities, to be issued on 29 October 2025, underscore the company&...
ALS Limited Announces Lapse of 27,926 Performance Rights
Jan 11, 2026
ALS Limited has disclosed that 27,926 performance rights (ASX code: ALQAA) have lapsed after the conditional rights to securities failed to meet, or became incapable of meeting, the required vesting conditions. The cessation of these securities, e...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.